Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Cureus|June 12, 2023
Comparison of Two Chemotherapy Regimens After First-Line Treatment for HER2-Negative Metastatic Gastric CancerZuhat Urakçı, Senar Ebinç, Sezai Tunç, et al.
Breast Cancer (Tokyo, Japan)|January 4, 2014
Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumabMuhammet Ali Kaplan, Hamza Ertugrul, Ugur Firat, et al.
Lung India : Official Organ of Indian Chest Society|November 16, 2011
Clinical characteristics and treatment outcomes in 132 patients with malignant mesotheliomaAbdurrahman Abakay, Abdullah C Tanrikulu, Muhammet Ali Kaplan, et al.
Nuclear Medicine Communications|August 9, 2021
Efficacy of 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting response to second-generation androgen receptor axis-targeted therapy, and the prognosis in metastatic hormone-refractory prostate cancer patientsZeynep Oruç, Yunus Güzel, Senar Ebinç, et al.
Cureus|February 8, 2023
Neoadjuvant Therapy and Factors Influencing Survival in Locally Advanced Non-Small Cell Lung CancerSenar Ebinç, Zeynep Oruç, Ziya Kalkan, et al.
Medical Oncology (Northwood, London, England)|November 16, 2011
Type 2 diabetes mellitus and prognosis in early stage breast cancer womenMuhammet Ali Kaplan, Zafer Pekkolay, Mehmet Kucukoner, et al.
Tumori|December 12, 2013
Efficacy and safety of concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced nasopharyngeal cancersMeltem Baykara, Suleyman Buyukberber, Banu Ozturk, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 4, 2013
Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancersMeltem Baykara, Suleyman Buyukberber, Banu Ozturk, et al.
Annali Italiani Di Chirurgia|December 26, 2024
Superiority of Pathologic Lymph Node Ratio over Positive Lymph Node Count in Operated Early-Stage Breast CancerZuhat Urakçı, Muhammet Ali Kaplan, Zeynep Oruç, et al.
Future Oncology (London, England)|September 7, 2022
Factors influencing HER2 discordance in nonmetastatic breast cancer and the role of neoadjuvant therapySenar Ebinç, Zeynep Oruç, Yasin Sezgin, et al.
Pageof 5